Drug stocks slip into negative territory
Drug stocks slip into negative territory
) were down 1% at $59.97. Allergan's stock gained more than 10% Thursday on news that two Phase III clinical studies showed its anti-wrinkle drug Botox was effective in battling chronic migraine hea…
Add A Comment